GSDMD and metabolic dysfunction-associated steatohepatitis: HFD upregulates the expressions of proinflammatory, NASH-related hepatic macrophage markers, guanylate binding proteins, caspase-11, and increases N-terminal gasdermin D (GSDMD) cleavage